Quantcast

Latest BSD Medical Corporation Stories

2008-11-05 09:00:34

SALT LAKE CITY, Nov. 5, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that an article titled "Neoadjuvant Treatment of Locally Advanced Soft Tissue Sarcoma of the Limbs: Which Treatment to Choose?" was published in The Oncologist (2008;13:175-186) by Peter Hohenberger and Wojciech M. Wysocki. The article reviewed different cancer treatment regimens for treating soft tissue sarcoma (a cancer that occurs in the connective tissues such as muscle), including...

2008-10-29 09:00:00

SALT LAKE CITY, Oct. 29, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that an article titled "Hyperthermia induced targeting of thermosensitive gene carriers to tumors" was published in a recent edition of Human Gene Therapy, the official journal of the European Society of Gene and Cell Therapy (Pubmed 18729717). Researchers from Ludwig-Maximilians University, Pharmaceutical Biology-Biotechnology, Department of Pharmacy, Munich, Germany "developed a gene...

2008-10-27 09:00:12

SALT LAKE CITY, Oct. 27, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today reported that the company well exceeded its goal and was among the top participants in its local area in the American Cancer Society "Making Strides Against Breast Cancer" walkathon as part of the National Breast Cancer Awareness Month (NBCAM). October is designated as National Breast Cancer Awareness Month in the United States. Working in partnership with other local businesses and individuals, the...

2008-10-14 09:00:45

SALT LAKE CITY, Oct. 14, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) announced today that a member of its Board of Directors, Dr. Michael Nobel, was the keynote speaker at the Japanese Cancer Symposium recently concluded at the Shizuoka Cancer Center in Shizuoka, Japan. The symposium addressed the theme, "Fulfilling the Promise of Personalized Medicine in Cancer Therapy: Development of the Medical Engineering Platform." The symposium was sponsored by the Frontier...

2008-10-08 09:00:51

SALT LAKE CITY, Oct. 8, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) announced today that the company will present its BSD-2000 hyperthermia therapy system as well as its MicroThermX-100 ablation system (which is being prepared for SFDA submission in China) at the 2008 China Medical Equipment Fair (CMEF) from October 29 through November 1, 2008 in Suzhou, China. The company's objective at CMEF is to leverage the growing clinical interest in the use of BSD Medical's systems...

2008-09-15 09:00:57

SALT LAKE CITY, Sept. 15, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today reported that a new article in Current Option in Oncology (see 2008, 20:pages 438-443) highlights strong success from the use of the BSD-2000 manufactured by BSD Medical Corporation, in treating patients with high risk soft tissue sarcomas. Central to the article's review of sarcoma studies using the BSD-2000 is the results of a phase III study involving 341 randomized patients with high risk soft...

2008-08-20 09:01:30

SALT LAKE CITY, Aug. 20, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that a report of two case studies has been published in the current issue of the International Journal of Hyperthermia (see vol. 4, pp. 327-335) that demonstrate the ability of the BSD-2000/3D/MR to produce high quality thermal imaging of cancer treatments in progress, even when interfering frequencies are introduced. The results of these studies are significant in showing the versatility...

2008-07-31 09:01:26

SALT LAKE CITY, July 31, 2008 (PRIME NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that the company's most advanced cancer treatment system, the BSD-2000/3D/MR, has been adapted to treat children with cancer, as well as adults. To accommodate the treatment of children, BSD Medical has developed sophisticated treatment applicators that are specifically sized for small and medium-sized children, and that are capable of delivering pediatric cancer therapy during simultaneous...

2008-07-17 15:01:02

SALT LAKE CITY, July 17, 2008 (PRIME NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that a formal response has been hand delivered to the Food and Drug Administration (FDA) pertaining to the BSD-2000 Hyperthermia System submission that is currently in review by the FDA. The response followed an in-person meeting with the FDA management and reviewers in which the company's response strategy was discussed before the company made its formal response. On January 7, 2008, the...

2008-06-30 09:03:37

BSD Medical Corporation (NASDAQ:BSDM) today provided an update on the status of the company's submissions to the Food and Drug Administration (FDA). BSD currently has two FDA submissions in progress, a premarket (PMA) submission for the BSD-2000 Hyperthermia System and a 510(k) premarket notification seeking FDA marketing clearance for the MicroThermX-100 Ablation System. On January 7, 2008 the company announced that it had received a letter from the FDA regarding its PMA submission for...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.